Daniel M. Togasaki

2.1k total citations
25 papers, 1.3k citations indexed

About

Daniel M. Togasaki is a scholar working on Cellular and Molecular Neuroscience, Neurology and Molecular Biology. According to data from OpenAlex, Daniel M. Togasaki has authored 25 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cellular and Molecular Neuroscience, 12 papers in Neurology and 9 papers in Molecular Biology. Recurrent topics in Daniel M. Togasaki's work include Neuroscience and Neuropharmacology Research (11 papers), Parkinson's Disease Mechanisms and Treatments (10 papers) and Neurological disorders and treatments (6 papers). Daniel M. Togasaki is often cited by papers focused on Neuroscience and Neuropharmacology Research (11 papers), Parkinson's Disease Mechanisms and Treatments (10 papers) and Neurological disorders and treatments (6 papers). Daniel M. Togasaki collaborates with scholars based in United States, Canada and Belgium. Daniel M. Togasaki's co-authors include Vernice Jackson‐Lewis, David M. Donaldson, Mayra Ferreira, Hong Jiang, Michael W. Jakowec, Giselle M. Petzinger, Marta Vučković, Maryka Quik, Donato A. Di Monte and J. William Langston and has published in prestigious journals such as Journal of Neuroscience, Stroke and Annals of Neurology.

In The Last Decade

Daniel M. Togasaki

25 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel M. Togasaki United States 18 795 742 265 166 149 25 1.3k
Vincenza Bagetta Italy 20 668 0.8× 1.0k 1.4× 345 1.3× 182 1.1× 123 0.8× 26 1.4k
Paula Ravenscroft France 22 1.2k 1.5× 1.2k 1.6× 327 1.2× 107 0.6× 121 0.8× 30 1.7k
Mahmoud M. Iravani United Kingdom 26 854 1.1× 1.0k 1.4× 388 1.5× 284 1.7× 191 1.3× 55 1.7k
Yuen‐Sum Lau United States 23 486 0.6× 660 0.9× 513 1.9× 117 0.7× 307 2.1× 45 1.5k
Michael F. Salvatore United States 24 699 0.9× 1.1k 1.5× 439 1.7× 168 1.0× 213 1.4× 58 1.7k
Rosa Luisa Potenza Italy 21 357 0.4× 699 0.9× 455 1.7× 199 1.2× 123 0.8× 38 1.2k
Laurent Grégoire Canada 31 1.4k 1.7× 1.5k 2.0× 448 1.7× 113 0.7× 106 0.7× 54 2.3k
Amanda Smith United States 21 466 0.6× 642 0.9× 389 1.5× 283 1.7× 228 1.5× 32 1.6k
Belén Gago Spain 21 332 0.4× 654 0.9× 439 1.7× 92 0.6× 174 1.2× 47 1.1k
R. Boucher Canada 26 1.0k 1.3× 1.2k 1.6× 370 1.4× 142 0.9× 133 0.9× 48 2.0k

Countries citing papers authored by Daniel M. Togasaki

Since Specialization
Citations

This map shows the geographic impact of Daniel M. Togasaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel M. Togasaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel M. Togasaki more than expected).

Fields of papers citing papers by Daniel M. Togasaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel M. Togasaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel M. Togasaki. The network helps show where Daniel M. Togasaki may publish in the future.

Co-authorship network of co-authors of Daniel M. Togasaki

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel M. Togasaki. A scholar is included among the top collaborators of Daniel M. Togasaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel M. Togasaki. Daniel M. Togasaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berkovich, Regina, Daniel M. Togasaki, Steven Cen, & Lawrence Steinman. (2015). CD4 cell response to interval therapy with natalizumab. Annals of Clinical and Translational Neurology. 2(5). 570–574. 6 indexed citations
2.
Wills, Anne‐Marie, Shirley Eberly, Marsha Tennis, et al.. (2013). Caffeine consumption and risk of dyskinesia in CALM‐PD. Movement Disorders. 28(3). 380–383. 41 indexed citations
3.
Factor, Stewart A., Kenneth Wolski, Daniel M. Togasaki, et al.. (2013). Long‐term safety and efficacy of preladenant in subjects with fluctuating Parkinson's disease. Movement Disorders. 28(6). 817–820. 38 indexed citations
4.
Vučković, Marta, Ruth I. Wood, Daniel P. Holschneider, et al.. (2008). Memory, mood, dopamine, and serotonin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury. Neurobiology of Disease. 32(2). 319–327. 90 indexed citations
5.
Cox, Henry, et al.. (2007). The selective κ-opioid receptor agonist U50,488 reduces l-dopa-induced dyskinesias but worsens parkinsonism in MPTP-treated primates. Experimental Neurology. 205(1). 101–107. 29 indexed citations
6.
Petzinger, Giselle M., John Walsh, Garnik Akopian, et al.. (2007). Effects of Treadmill Exercise on Dopaminergic Transmission in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Lesioned Mouse Model of Basal Ganglia Injury. Journal of Neuroscience. 27(20). 5291–5300. 269 indexed citations
7.
Togasaki, Daniel M., et al.. (2005). Enhanced striatal opioid receptor-mediated G-protein activation in l-dopa-treated dyskinetic monkeys. Neuroscience. 132(2). 409–420. 38 indexed citations
8.
Togasaki, Daniel M., et al.. (2005). Dyskinesias in normal squirrel monkeys induced by nomifensine and levodopa. Neuropharmacology. 48(3). 398–405. 11 indexed citations
9.
Togasaki, Daniel M., et al.. (2005). The Webcam system: a simple, automated, computer-based video system for quantitative measurement of movement in nonhuman primates. Journal of Neuroscience Methods. 145(1-2). 159–166. 26 indexed citations
10.
Togasaki, Daniel M., Erwan Bézard, Pierre Sokoloff, et al.. (2004). Effect of the D3 Dopamine Receptor Partial Agonist BP897 [N-[4-(4-(2-Methoxyphenyl)piperazinyl)butyl]-2-naphthamide] on l-3,4-Dihydroxyphenylalanine-Induced Dyskinesias and Parkinsonism in Squirrel Monkeys. Journal of Pharmacology and Experimental Therapeutics. 311(2). 770–777. 38 indexed citations
11.
Tan, Louis C.S., et al.. (2002). The hyperkinetic abnormal movements scale: A tool for measuring levodopa‐induced abnormal movements in squirrel monkeys. Movement Disorders. 17(5). 902–909. 17 indexed citations
12.
Togasaki, Daniel M., et al.. (2002). Reply. Annals of Neurology. 51(4). 531–532. 2 indexed citations
13.
Yee, Randa E., Ian Irwin, D. B. Stout, et al.. (2001). Novel observations with FDOPA‐PET imaging after early nigrostriatal damage. Movement Disorders. 16(5). 838–848. 32 indexed citations
14.
Togasaki, Daniel M., et al.. (2001). Levodopa induces dyskinesias in normal squirrel monkeys. Annals of Neurology. 50(2). 254–257. 44 indexed citations
15.
16.
Dethy, Sophie, Daniel M. Togasaki, Serge Przedborski, et al.. (1996). Systemic and intrastriatal theophylline have opposite effects on dopamine and dopamine metabolites measured by intrastriatal microdialysis in the rat. Neuroscience Letters. 208(3). 159–162. 6 indexed citations
17.
Parsons, Bruce, Daniel M. Togasaki, Suham Kassir, & Serge Przedborski. (1995). Neuroleptics Up‐Regulate Adenosine A2a Receptors in Rat Striatum: Implications for the Mechanism and the Treatment of Tardive Dyskinesia. Journal of Neurochemistry. 65(5). 2057–2064. 49 indexed citations
18.
Jiang, Hong, et al.. (1995). Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by instrastriatal injection of 6-hydroxydopamine. Neuroscience. 67(3). 631–647. 357 indexed citations
19.
Levivier, Marc, et al.. (1994). Quantitative assessment of quinolinic acid-induced striatal toxicity in rats using radioligand binding assays. Neurological Research. 16(3). 194–200. 22 indexed citations
20.
Arnold, Michael, et al.. (1982). Caffeine stimulates β-endorphin release in blood but not in cerebrospinal fluid. Life Sciences. 31(10). 1017–1024. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vincenza Bagetta Breakdown of academic impact, for papers by Paula Ravenscroft Breakdown of academic impact, for papers by Mahmoud M. Iravani Breakdown of academic impact, for papers by Yuen‐Sum Lau Breakdown of academic impact, for papers by Michael F. Salvatore Breakdown of academic impact, for papers by Rosa Luisa Potenza Breakdown of academic impact, for papers by Laurent Grégoire Breakdown of academic impact, for papers by Amanda Smith Breakdown of academic impact, for papers by Belén Gago Breakdown of academic impact, for papers by R. Boucher
Rankless by CCL
2026